Andrew R Zullo1, Yoojin Lee1, Lori A Daiello1, Vincent Mor1,2, W John Boscardin3,4,5, David D Dore1,6, Yinghui Miao3,4, Kathy Z Fung3,4, Kiya D R Komaiko3,4, Michael A Steinman3,4. 1. Department of Health Services, Policy, and Practice, School of Public Health, Brown University, Providence, Rhode Island. 2. Center of Innovation, Providence Veterans Affairs Medical Center, Providence, Rhode Island. 3. Division of Geriatrics, University of California, San Francisco, San Francisco, California. 4. San Francisco Veterans Affairs Medical Center, San Francisco, California. 5. Division of Biostatistics, University of California, San Francisco, San Francisco, California. 6. Optum Epidemiology, Boston, Massachusetts.
Abstract
OBJECTIVES: To evaluate how often beta-blockers were started after acute myocardial infarction (AMI) in nursing home (NH) residents who previously did not use these drugs and to evaluate which factors were associated with post-AMI use of beta-blockers. DESIGN: Retrospective cohort using linked national Minimum Data Set assessments; Online Survey, Certification and Reporting records; and Medicare claims. SETTING: U.S. NHs. PARTICIPANTS: National cohort of 15,720 residents aged 65 and older who were hospitalized for AMI between May 2007 and March 2010, had not taken beta-blockers for at least 4 months before their AMI, and survived 14 days or longer after NH readmission. MEASUREMENTS: The outcome was beta-blocker initiation within 30 days of NH readmission. RESULTS: Fifty-seven percent (n = 8,953) of residents initiated a beta-blocker after AMI. After covariate adjustment, use of beta-blockers was less in older residents (ranging from odds ratio (OR) = 0.89, 95% confidence interval (CI) = 0.79-1.00 for aged 75-84 to OR = 0.65, 95% CI = 0.54-0.79 for ≥95 vs 65-74) and less in residents with higher levels of functional impairment (dependent or totally dependent vs independent to limited assistance: OR = 0.84, 95% CI = 0.75-0.94) and medication use (≥15 vs ≤10 medications: OR = 0.89, 95% CI = 0.80-0.99). A wide variety of resident and NH characteristics were not associated with beta-blocker use, including sex, cognitive function, comorbidity burden, and NH ownership. CONCLUSION: Almost half of older NH residents in the United States do not initiate a beta-blocker after AMI. The absence of observed factors that strongly predict beta-blocker use may indicate a lack of consensus on how to manage older NH residents, suggesting the need to develop and disseminate thoughtful practice standards.
OBJECTIVES: To evaluate how often beta-blockers were started after acute myocardial infarction (AMI) in nursing home (NH) residents who previously did not use these drugs and to evaluate which factors were associated with post-AMI use of beta-blockers. DESIGN: Retrospective cohort using linked national Minimum Data Set assessments; Online Survey, Certification and Reporting records; and Medicare claims. SETTING: U.S. NHs. PARTICIPANTS: National cohort of 15,720 residents aged 65 and older who were hospitalized for AMI between May 2007 and March 2010, had not taken beta-blockers for at least 4 months before their AMI, and survived 14 days or longer after NH readmission. MEASUREMENTS: The outcome was beta-blocker initiation within 30 days of NH readmission. RESULTS: Fifty-seven percent (n = 8,953) of residents initiated a beta-blocker after AMI. After covariate adjustment, use of beta-blockers was less in older residents (ranging from odds ratio (OR) = 0.89, 95% confidence interval (CI) = 0.79-1.00 for aged 75-84 to OR = 0.65, 95% CI = 0.54-0.79 for ≥95 vs 65-74) and less in residents with higher levels of functional impairment (dependent or totally dependent vs independent to limited assistance: OR = 0.84, 95% CI = 0.75-0.94) and medication use (≥15 vs ≤10 medications: OR = 0.89, 95% CI = 0.80-0.99). A wide variety of resident and NH characteristics were not associated with beta-blocker use, including sex, cognitive function, comorbidity burden, and NH ownership. CONCLUSION: Almost half of older NH residents in the United States do not initiate a beta-blocker after AMI. The absence of observed factors that strongly predict beta-blocker use may indicate a lack of consensus on how to manage older NH residents, suggesting the need to develop and disseminate thoughtful practice standards.
Authors: Becky A Briesacher; Stephen B Soumerai; Terry S Field; Hassan Fouayzi; Jerry H Gurwitz Journal: J Am Geriatr Soc Date: 2009-08-21 Impact factor: 5.562
Authors: Andrew R Zullo; Michelle Hersey; Yoojin Lee; Sadia Sharmin; Elliott Bosco; Lori A Daiello; Nishant R Shah; Vincent Mor; W John Boscardin; Christine M Berard-Collins; David D Dore; Michael A Steinman Journal: Diabetes Obes Metab Date: 2018-07-22 Impact factor: 6.577
Authors: Andrew R Zullo; Matthew Olean; Sarah D Berry; Yoojin Lee; Jennifer Tjia; Michael A Steinman Journal: J Gerontol A Biol Sci Med Sci Date: 2019-07-12 Impact factor: 6.053
Authors: Andrew R Zullo; Sadia Sharmin; Yoojin Lee; Lori A Daiello; Nishant R Shah; W John Boscardin; David D Dore; Sei J Lee; Michael A Steinman Journal: J Am Geriatr Soc Date: 2017-10-17 Impact factor: 5.562
Authors: Andrew R Zullo; Amanda Mogul; Katherine Corsi; Nishant R Shah; Sei J Lee; James L Rudolph; Wen-Chih Wu; Ruth Dapaah-Afriyie; Christine Berard-Collins; Michael A Steinman Journal: Circ Cardiovasc Qual Outcomes Date: 2019-04
Authors: Deborah S Lee; Andrew R Zullo; Yoojin Lee; Lori A Daiello; Dae Hyun Kim; Douglas P Kiel; Sarah D Berry Journal: J Am Geriatr Soc Date: 2021-10-20 Impact factor: 7.538
Authors: Michael A Steinman; Andrew R Zullo; Yoojin Lee; Lori A Daiello; W John Boscardin; David D Dore; Siqi Gan; Kathy Fung; Sei J Lee; Kiya D R Komaiko; Vincent Mor Journal: JAMA Intern Med Date: 2017-02-01 Impact factor: 21.873
Authors: Andrew R Zullo; Richard Ofori-Asenso; Marci Wood; Allison Zuern; Yoojin Lee; Wen-Chih Wu; James L Rudolph; Danny Liew; Michael A Steinman Journal: J Am Med Dir Assoc Date: 2020-03-03 Impact factor: 4.669
Authors: Andrew R Zullo; Melissa R Riester; Sebhat Erqou; Wen-Chih Wu; James L Rudolph; Michael A Steinman Journal: Drugs Aging Date: 2020-10 Impact factor: 3.923